Brief: Kintor Pharmaceutical Says Unit Entered Brand And Sales Operation Cooperation Agreement
12/03/2025 10:24
March 12 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK: UNIT ENTERED INTO A BRAND AND SALES OPERATION COOPERATION AGREEMENT WITH HANGZHOU TOMAX DEAL FOR BUSINESS COOPERATION IN SALES AGENCY, BRAND OPERATIONS AND MARKET PROMOTION OF CO'S COSMETICS, OTHERS Further company coverage: 9939.HK ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint